Antimicrobial Activity of Ceftazidime-Avibactam and Comparators against Pathogens Harboring OXA-48 and AmpC Alone or in Combination with Other β-Lactamases Collected from Phase 3 Clinical Trials and an International Surveillance Program

In vitro activities of ceftazidime-avibactam (CAZ-AVI) and key comparators against AmpC-overproducing Enterobacterales and Pseudomonas aeruginosa isolates from four Phase 3 clinical trials and against OXA-48–producing Enterobacterales with multiple resistance mechanisms from the Antimicrobial Testin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Lynn-Yao, Debabov, Dmitri, Chang, William, Stone, Gregory, Riccobene, Todd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Epidemiology and Surveillance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923174/
https://www.ncbi.nlm.nih.gov/pubmed/35225651
http://dx.doi.org/10.1128/aac.01985-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923174/
https://www.ncbi.nlm.nih.gov/pubmed/35225651
http://dx.doi.org/10.1128/aac.01985-21

Ejemplares similares